Syndax Pharmaceuticals
SNDX
SNDX
45 hedge funds and large institutions have $176M invested in Syndax Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
45
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$13.3M | |
| 2 | +$4.47M | |
| 3 | +$2.52M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.87M |
| 5 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
+$1.74M |
Top Sellers
| 1 | -$2.47M | |
| 2 | -$2.33M | |
| 3 | -$259K | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$244K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$140K |